New Delhi: Genestrings Diagnostic Centre’s lab at the Delhi international airport has been appointed by the Canadian government as the sole COVID-19 testing facility in India for Canada-bound passengers, a statement said on Monday.
As per the latest guidelines by the Canadian authorities, travellers eligible to enter Canada and travelling on direct flights from India must obtain a pre-departure negative COVID-19 molecular test result from the Genestrings‘ lab, the statement said.
The facility – which is located above the metro station in the Airport Connect Building (ACB) at the Delhi international airport – will perform this test within 18 hours before the scheduled departure of the passengers and a test report with a QR code will be given to them, it said.
The QR code given by the lab has to be shown to the airline just before boarding, it added.
Canada lifted the flight ban on passenger flights from India on September 27. Air Canada is currently operating two to four flights every day from the Delhi airport, the statement said.
Currently, flights to Canada are being operated from only Delhi in India.
The confidence shown by Canadian Health Agency in our lab is testimony to our near obsessed focus on ensuring the highest standards of quality testing, and we are really proud of the team that works 24/7 365 days a year to deliver this, said Dr Gauri Agarwal, founder-director, Genestrings Diagnostic Centre.
Also read | Australia to lift 18-month COVID-19 travel ban
- Experts explain what is causing heavy rains in Uttarakhand, Kerala
- Sheikh Hasina orders immediate action against those who incited violence using religion
- VHP stages protest in West Bengal, Assam over attacks on minorities in Bangladesh
- Northeast to be developed as India’s bio-economic hub: Jitendra Singh
- Sikkim logs 27 new COVID-19 cases, 1 fresh fatality
- IIT-Delhi to offer BTech course in Energy Engineering from 2021 academic session